Bioactive Compounds
-
BA1897 CenicrivirocSummary: Cenicriviroc (TAK-652) is an orally available dual antagonist. -
B1673 BenzbromaroneSummary: TMEM16A/B calcium-activated chloride channel (CaCC) blocker -
BA1896 BictegravirSummary: Bictegravir (GS-9883) is a potent integrase inhibitor. -
B1654 AloperineSummary: An alkaloid -
BA1895 ABBV-744Summary: ABBV-744 is a first-of-its-kind, orally active and selective BDII structural domain of the BET family of proteins. -
B1579 JIB-041 CitationTarget: Histone DemethylasesSummary: Jumonji histone demethylase inihibitor -
BA1893 TucaresolSummary: Tucaresol is an orally bioavailable immune-enhancing drug that enhances T helper cell activity. -
B1524 Erastin31 CitationTarget: RasSummary: ferroptosis inducer -
BA1892 JTK-109Summary: JTK-109 is a potent inhibitor of hepatitis C virus RNA-dependent RNA polymerase. -
B1238 Cidofovir dihydrateSummary: Antiviral agent for CMV

